Abstract
The present invention provides stable, dry powder messenger RNA formulations for therapeutic use, and methods of making and using the same.
Full Text
What is claimed is:
The present invention provides stable, dry powder messenger RNA formulations for therapeutic use, and methods of making and using the same.
Timeline
Filed
03/18/2026Published
07/09/2026Granted
Not AvailableIPC Codes(8)
A61K 9/50:Microcapsules (takes precedence A61K 9/52)
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 9/48:Preparations in capsules, e.g. of gelatin, of chocolate